Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-17

Clinical Trial Update: Quality of Life Study in Adults With Facial Eczema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating quality of life in adults with facial eczema (atopic dermatitis) sponsored by Novartis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Novartis | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED